Malunga-nomhlaza / unyango / iziyobisi / i-myeloproliferative-neoplasms

Iziyobisi ezivunyiweyo zeMyeloproliferative Neoplasms

Eli phepha liluhlu lweziyobisi zomhlaza ezivunywe nguLawulo lokutya kunye noLawulo lweeDrug (FDA) ze-myeloproliferative neoplasms. Uluhlu lubandakanya amagama aqhelekileyo kunye nophawu. Eli phepha likwadwelisa indibaniselwano yamachiza aqhelekileyo asetyenziswa kwiipropu ze-myeloproliferative. Amachiza ngamanye kwindibaniselwano amkelwe yi-FDA. Nangona kunjalo, indibaniselwano yeziyobisi ngokwazo zihlala zingavunyelwanga, kodwa zisetyenziswa ngokubanzi.

Amagama amachiza adibanisa nesishwankathelo soLwazi lweCancer yeziyobisi. Kunokubakho amachiza asetyenziswa kwiimpawu ze-myeloproliferative ezingadweliswanga apha.

Iziyobisi ezivunyiweyo zeMyeloproliferative Neoplasms

IAdriamycin PFS (iDoxorubicin Hydrochloride)

Iadriamycin RDF (iDoxorubicin Hydrochloride)

IArsenic Trioxide

I-Azacitidine

ICerubidine (iDaunorubicin Hydrochloride)

IClafen (iCyclophosphamide)

Cyclophosphamide

ICytarabine

ICytosar-U (iCytarabine)

ICytoxan (iCyclophosphamide)

IDacogen (iCititabine)

Dasatinib

IDaunorubicin Hydrochloride

Decitabine

I-Doxorubicin Hydrochloride

IFedratinib Hydrochloride

I-Gleevec (Imatinib Mesylate)

Imatinib Mesylate

Inrebic (IFedratinib Hydrochloride)

Jakafi (Ruxolitinib Phosphate)

Nilotinib

I-Rubidomycin (iDaunorubicin Hydrochloride)

Ruxolitinib Iphosphate

ISprycel (iDasatinib)

I-Tarabine PFS (iCytarabine)

Tasigna (Nilotinib)

I-Trisenox (iAsenic Trioxide)

IVidaza (iAzacitidine)

Umdibaniso weziyobisi osetyenziswa kwiMeloproliferative Neoplasms

Yongeza